Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atrial Cardiomyopathy in Patients With Cardiovascular-Kidney-Metabolic Syndrome: Non-invasive Characterization (ATRIO-CKM)

NCT07697469 is registered in ClinicalTrials.gov with Grigore T. Popa University of Medicine and Pharmacy as lead sponsor.

NCT NCT07697469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07697469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atrial Cardiomyopathy in Patients With Cardiovascular-Kidney-Metabolic Syndrome: Non-invasive Characterization (ATRIO-CKM)
Lead sponsor
Grigore T. Popa University of Medicine and Pharmacy
Phase
Observational
Overall status
Not yet recruiting
Start date
July 10, 2026
Completion date
April 30, 2028
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial cardiomyopathy, atrial fibrillation, cardiovascular-kidney-metabolic syndrome, chronic kidney disease, metabolic syndrome